Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
eNq1mFFv2jAQx9/5FFHeSRpoC50C1cbaDanVGC3atJfKJEcxC3Z6tgns088hdKOTo64GP8Z2/ne+O/98cny5XmbeClBQznp+FJz4HrCEp5Q99vzJ/XWz61/2G/GCrMjesk5wEkQt30syIkTPL2eDKRAmgu+3Nx9B/w/o9xtezKcLSOSLdUrSLPhMxPyW5OUaL15xmnpLkHOe9vxcye2oFwuJ2ot+wfGnyEkCcbgb2Z9dPJzuj8dhKfYfqkoA3hD2aBQFZqWZKERgckAkPHLc1PjbttKmYgyCK0xgROR8hHxFU0iNJmYkE2BlZFakd4CrDGRpxCgeLpKlsBInC7Iew9PQ7PR7PTuQa9k8aUad04tWu9Ntt08ju2DhXqjMWdCbCJOHqNOKup3zEFhYbIQky6VlbkYcJckcZYWKwcvCcmQH4enV7KdU5BnZBAuR24aKINHTgPr4u9tIuYN71EDKdMz+0Wcqy8I3ej3Z4cKRxyWNBlwxWUON67FtIAacSVjXZ9QOdHK9q0UK4niyvzgzQ36kphlNbJGmoaNAyMl4WE+0Y8LgAxEwQXc0+EZZygtxfMrsZ9WR9/kWlEbRHNPooXXRPY/OzqwP0Q9dQjU3zJVCnkOo+UPFIVgZshk/FCi6Ks1SzzV5tHLc9jk8IRnUdDpNS7boOnxuzJxVurtTVE0YRT9d3duWx1cFuLnbfhqladr7k1g78LqguS7GWsffXtrVCXfSAys0k2MuZS7ehWFRFMGciKYgOkrBDI9O9r3L1F0H7uTGrjqYio6OXJ9W197bMmR70l670w/tU3f/7/phow2JCg7IRQVlZ+gcXh2fxn+bVGduj17Qw52ZbUNJJOXMVaOjpkbFw/iv88quUQPiy2xGa15EausyDqvXmH4jDsuXmH7jN41B5VU=
YnTJBawgFsUnG9e1
Listen
